Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CYP1A2 | P05177 | 2/20 | 0.47 |
| ▸ | CYP2A6 | P11509 | 2/20 | 0.47 |
| ▸ | TSHR | P16473 | 2/20 | 0.47 |
| ▸ | ACHE | P22303 | 1/20 | 0.47 |
| ▸ | ALDH1A1 | P00352 | 4/20 | 0.45 |
| ▸ | CA1 | P00915 | 1/20 | 0.45 |
| ▸ | CA2 | P00918 | 1/20 | 0.45 |
| ▸ | CA7 | P43166 | 1/20 | 0.45 |
| ▸ | CA9 | Q16790 | 1/20 | 0.45 |
| ▸ | P2RX7 | Q99572 | 1/20 | 0.42 |
| ▸ | GRIN2D | O15399 | 1/20 | 0.41 |
| ▸ | GRIN3B | O60391 | 1/20 | 0.41 |
| ▸ | GRIN1 | Q05586 | 1/20 | 0.41 |
| ▸ | GRIN2A | Q12879 | 1/20 | 0.41 |
| ▸ | GRIN2B | Q13224 | 1/20 | 0.41 |
| ▸ | GRIN2C | Q14957 | 1/20 | 0.41 |
| ▸ | GRIN3A | Q8TCU5 | 1/20 | 0.41 |
| ▸ | SIGMAR1 | Q99720 | 1/20 | 0.41 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.41 |
| ▸ | MEN1 | O00255 | 1/20 | 0.40 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL22280009 | 0.85 | CYP1A2 (0.41) | CYP1A2CYP2A6TSHRACHEALDH1A1 | |
| SCHEMBL22169098 | 0.84 | ALDH1A1 (0.57) | CYP1A2TSHRACHEALDH1A1P2RX7 | |
| SCHEMBL14753773 | 0.83 | ALDH1A1 (0.41) | CYP1A2CYP2A6TSHRACHEALDH1A1 | |
| SCHEMBL11171249 | 0.81 | PTGS2 (0.50) | ALDH1A1MEN1KMT2APOLB | |
| SCHEMBL2927525 | 0.80 | ALDH1A1 (0.54) | CYP1A2CYP2A6TSHRACHEALDH1A1 | |
| SCHEMBL1006539 | 0.78 | CYP1A2 (0.45) | CYP1A2CYP2A6TSHRACHEALDH1A1 | |
| SCHEMBL5083013 | 0.78 | RAPGEF4 (0.52) | CYP1A2CYP2A6ALDH1A1MEN1KMT2A | |
| SCHEMBL11124720 | 0.78 | GAA (0.52) | CYP1A2CYP2A6TSHRALDH1A1MEN1 | |
| SCHEMBL11249001 | 0.77 | P2RX7 (0.64) | CYP1A2ALDH1A1P2RX7L3MBTL1MEN1 | |
| SCHEMBL9644071 | 0.75 | CYP1A2 (0.43) | CYP1A2CYP2A6TSHRACHEALDH1A1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2022149487-A1 | METHOD FOR TESTING POSSIBILITY OF HAVING CONTRACTED PROSTATE CANCER | 住友化学株式会社 | 2022-07-14 | — | — | WO | claimed |
| EP-1971568-B1 | PROCESS FOR CONTINUOUS PREPARATION OF A PRIMARY AROMATIC AMINE | BASF SE (DE) | 2011-08-03 | — | — | EP | claimed |
| WO-2022149487-A1 | METHOD FOR TESTING POSSIBILITY OF HAVING CONTRACTED PROSTATE CANCER | 住友化学株式会社 | 2022-07-14 | — | — | WO | disclosed |
| CN-107144644-A | It is vertical to reach the mould assay method about material | 上海海洋大学 | 2017-09-08 | — | — | CN | disclosed |
| US-20120071692-A1 | PROCESS FOR THE PREPARATION OF AROMATIC AMINES | BASF SE (DE) | 2012-03-22 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20120071692-A1 | PROCESS FOR THE PREPARATION OF AROMATIC AMINES | ADH1A, ADH5, ADH1C | CYP1A2 44/4885CYP2A6 632/4885TSHR 997/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.